Alpha 2.0
Login Register
» Articles » PMID: 3456223

The Role of Raw Starches in the Treatment of Type I Glycogenosis

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 1986 Feb 1
PMID 3456223
Citations 7
Authors
J B Sidbury
Y T Chen
C R Roe
Affiliations
Soon will be listed here.
Citing Articles

Potential use of other starch sources in the treatment of glycogen storage disease type Ia - an in vitro study.

Monteiro V, Colonetti K, Pagno C, Schmidt H, Sperb-Ludwig F, de Oliveira B Orphanet J Rare Dis. 2024; 19(1):283.

PMID: 39080776 PMC: 11289971. DOI: 10.1186/s13023-024-03201-1.

A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia.

Monteiro V, de Oliveira B, Dos Santos B, Sperb-Ludwig F, Refosco L, Nalin T Orphanet J Rare Dis. 2021; 16(1):254.

PMID: 34082801 PMC: 8173866. DOI: 10.1186/s13023-021-01877-3.

The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.

Cappello A, Curcio R, Lappano R, Maggiolini M, Dolce V Front Chem. 2018; 6:122.

PMID: 29719821 PMC: 5913288. DOI: 10.3389/fchem.2018.00122.

A novel starch for the treatment of glycogen storage diseases.

Bhattacharya K, Orton R, Qi X, Mundy H, Morley D, Champion M J Inherit Metab Dis. 2007; 30(3):350-7.

PMID: 17514432 DOI: 10.1007/s10545-007-0479-0.

Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.

Roe C, Sweetman L, Roe D, David F, Brunengraber H J Clin Invest. 2002; 110(2):259-69.

PMID: 12122118 PMC: 151060. DOI: 10.1172/JCI15311.